Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00215969
Status:
UNKNOWN
Last Update Posted:
2006-02-02
First Post:
2005-09-14
Brief Title:
Prospective Study in Pregnant Women With Hypercoagulopathy
Sponsor:
Hillerod Hospital Denmark
Organization:
Hillerod Hospital Denmark
Study Overview
Official Title:
Prospective Study of Hypercoagulation in Pregnant Women
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pre-eclampsia is one of the most common causes of maternal and fetal morbidity and mortality The aim of this study is to identify pregnant women at risk for pre-eclampsia or other cardiovascular complications at a very early state of the disease and thereby improve the current method of screening
Detailed Description:
600 pregnant women will be included in the project and followed in a standardized manner during their pregnancy On a regular basis blood- and urine samples will be taken throughout their pregnancy and until 1 month after delivery and analyzed for a large variety of coagulation factors in order to identify factors that might predict an increased risk of developing pre-eclampsia andor cardiovascular events In addition a DNA-sample is taken if consented in order to evaluate genetic factors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None